Medication info
Januvia Tablet 50 mg (Sitagliptin Phosphate Hydrate)

Januvia Tablet 50 mg (Sitagliptin Phosphate Hydrate)

Prescription medicationTabletOral
Ingredient · strength
Sitagliptin Phosphate Hydrate›64.25mg / 1 tablet
Manufacturer / importer
Chong Kun Dang Pharm.
Appearance
A round, biconvex film-coated tablet that is light beige in color and has '112' engraved on one side.
Packaging
28 tablets (14 tablets/PTP x 2)
Approval status
Active

MFDS item code 200710758 · Approved 2007.09.21 · Insurance code 643309540

Summary

Main use
Improvement of blood glucose control in type 2 diabetes mellitus
Who takes it
Adults
Adult dose
This medicine is administered at a dose of 100 mg once daily as monotherapy or in combination therapy; the maximum daily dose is 100 mg. This medicine may be taken with or without food. When this medicine is administered in combination with a sulfonylurea or insulin, a reduction in the dose of the sulfonylurea or insulin may be considered to reduce the risk of sulfonylurea- or insulin-induced hypoglycemia (see Precautions for Use, 5. General Precautions). Patients with renal impairment As dosage adjustment based on renal function is necessary, assessment of renal function is recommended before starting this medicine and periodically during treatment. 1. No dosage adjustment is necessary in patients with mild renal impairment (estimated glomerular filtration rate [eGFR] ≥ 60 mL/min/1.73 m2 and < 90 mL/min/1.73 m2). 2. No dosage adjustment is necessary in patients with moderate renal impairment (estimated glomerular filtration rate [eGFR] ≥ 45 mL/min/1.73 m2 and < 60 mL/min/1.73 m2). 3. Administer 50 mg once daily in patients with moderate renal impairment (estimated glomerular filtration rate [eGFR] ≥ 30 mL/min/1.73 m2 and < 45 mL/min/1.73 m2). 4. Administer 25 mg once daily in patients with severe renal impairment (estimated glomerular filtration rate [eGFR] ≥ 15 mL/min/1.73 m2 and < 30 mL/min/1.73 m2) or end-stage renal disease (ESRD) requiring hemodialysis or peritoneal dialysis (estimated glomerular filtration rate [eGFR] < 15 mL/min/1.73 m2). This medicine may be administered regardless of the timing of dialysis.

Ingredients

Importer
Chong Kun Dang Pharm.

Efficacy & effects

Improvement of blood glucose control in type 2 diabetes mellitus

  • Blood sugar control problems in patients with type 2 diabetes
View approved original text

This medication is used to assist dietary and exercise therapy for improving blood sugar control in patients with type 2 diabetes. It can be used alone or in combination with other medications to increase therapeutic effects. This effectively supports blood sugar management, helping to improve the patient's health.

How to take

Adult dose

This medicine is administered at a dose of 100 mg once daily as monotherapy or in combination therapy; the maximum daily dose is 100 mg. This medicine may be taken with or without food. When this medicine is administered in combination with a sulfonylurea or insulin, a reduction in the dose of the sulfonylurea or insulin may be considered to reduce the risk of sulfonylurea- or insulin-induced hypoglycemia (see Precautions for Use, 5. General Precautions). Patients with renal impairment As dosage adjustment based on renal function is necessary, assessment of renal function is recommended before starting this medicine and periodically during treatment. 1. No dosage adjustment is necessary in patients with mild renal impairment (estimated glomerular filtration rate [eGFR] ≥ 60 mL/min/1.73 m2 and < 90 mL/min/1.73 m2). 2. No dosage adjustment is necessary in patients with moderate renal impairment (estimated glomerular filtration rate [eGFR] ≥ 45 mL/min/1.73 m2 and < 60 mL/min/1.73 m2). 3. Administer 50 mg once daily in patients with moderate renal impairment (estimated glomerular filtration rate [eGFR] ≥ 30 mL/min/1.73 m2 and < 45 mL/min/1.73 m2). 4. Administer 25 mg once daily in patients with severe renal impairment (estimated glomerular filtration rate [eGFR] ≥ 15 mL/min/1.73 m2 and < 30 mL/min/1.73 m2) or end-stage renal disease (ESRD) requiring hemodialysis or peritoneal dialysis (estimated glomerular filtration rate [eGFR] < 15 mL/min/1.73 m2). This medicine may be administered regardless of the timing of dialysis.

Precautions

This medication may cause severe allergic reactions. If symptoms such as skin rash or difficulty breathing occur, discontinue use immediately and consult a doctor. During treatment with this medication, symptoms of pancreatitis, an inflammation of the pancreas, may appear. If abdominal pain, vomiting, or persistent abdominal pain occurs, promptly inform a healthcare professional. Patients with type 1 diabetes or diabetic ketoacidosis should not take this medication, and those with hypersensitivity to this medication should also avoid it. Patients with impaired kidney function should have their dosage adjusted, so those with renal diseases should discuss appropriate dosing with their doctor. This drug can be used alone or in combination with other diabetes treatments, but when taken with insulin or sulfonylureas, the risk of hypoglycemia may increase, so regular monitoring of blood sugar is necessary. While taking this medication, symptoms such as headache, nasopharyngitis, upper respiratory tract infection, diarrhea, nausea, etc., may occur; if symptoms worsen, it is advisable to consult a healthcare professional. Severe joint pain or skin diseases such as bullous pemphigoid may develop; if these symptoms appear, immediately inform a doctor and stop taking the medication. This medication is not recommended for pregnant women or nursing mothers, so if there is a plan for pregnancy or if you are pregnant, you should definitely consult a doctor. Safety and efficacy have not been sufficiently confirmed in children, particularly those under 18 years old, so its use should be avoided. Elderly patients may have decreased kidney function, so it is necessary to have regular kidney function tests before and during the use of this medication. In cases of overdose, standard emergency measures should be taken, and if necessary, dialysis may be performed to remove the medication; thus, if the medication is taken incorrectly, contact a healthcare facility immediately.

Side effects

Anaphylaxis

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to prevent air from entering and kept at room temperature between 1°C and 25°C. Proper storage can help maintain the medication's effectiveness for a prolonged period.

Appearance and packaging

Appearance

A round, biconvex film-coated tablet that is light beige in color and has '112' engraved on one side.

Package unit

28 tablets (14 tablets/PTP x 2)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.